Hidradenitis Suppurativa: Disease Burden and Etiology in Skin of Color

被引:54
作者
Lee, Dylan E. [1 ]
Clark, Ashley K. [2 ]
Shi, Vivian Y. [3 ]
机构
[1] Creighton Univ, Sch Med, Omaha, NE USA
[2] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA
[3] Univ Arizona, Dept Med, Div Dermatol, 1515 N Campbell Ave,POB 245024,Bldg 222,Levy Bldg, Tucson, AZ 85724 USA
关键词
Hidradenitis suppurativa; Disease burden; Skin of color; METABOLIC SYNDROME; UNITED-STATES; SOCIOECONOMIC-STATUS; AFRICAN-AMERICANS; RANDOMIZED-TRIAL; CHINESE FAMILY; ACNE INVERSA; DOUBLE-BLIND; ADALIMUMAB; HEALTH;
D O I
10.1159/000486741
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Hidradenitis suppurativa (HS) is a chronic, debilitating skin disease. Although most studies on HS are conducted in largely Caucasian populations, evidence demonstrates a higher prevalence in patients with skin of color, including African and Hispanic populations. These racial subgroups are likely at risk for greater disease burden due to a higher prevalence of components of the metabolic syndrome, comorbid depression, and low socioeconomic status; however, there is a paucity of research in these populations. Additionally, studies examining the genetic and anatomical basis for HS, as well as the response to HS therapies, are lacking for patients with skin of color. Complicating this issue is the limited access to effective medical care, including dermatologists, for African and Hispanic populations as well as other minority groups. In this review, we identify gaps in the knowledge base, highlight the association between HS and patients with skin of color, and provide direction for much needed research into this condition. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:456 / 461
页数:6
相关论文
共 47 条
[1]   Hidradenitis suppurativa: A comprehensive review [J].
Alikhan, Ali ;
Lynch, Peter J. ;
Eisen, Daniel B. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (04) :539-561
[2]  
[Anonymous], 2015, DAN MED J
[3]   Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy [J].
Arenbergerova, Monika ;
Gkalpakiotis, Spyridon ;
Arenberger, Petr .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (12) :1445-1449
[4]   Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum [J].
Blok, J. L. ;
Li, K. ;
Brodmerkel, C. ;
Horvatovich, P. ;
Jonkman, M. F. ;
Horvath, B. .
BRITISH JOURNAL OF DERMATOLOGY, 2016, 174 (04) :839-846
[5]   Smoking and obesity are associated factors in acne inversa: results of a retrospective investigation in 100 patients [J].
Cesko, Elvir ;
Koerber, Andreas ;
Dissemond, Joachim .
EUROPEAN JOURNAL OF DERMATOLOGY, 2009, 19 (05) :490-493
[6]   γ-Secretase Mutation in an African American Family With Hidradenitis Suppurativa [J].
Chen, Sean ;
Mattei, Peter ;
You, Jing ;
Sobreira, Nara L. ;
Hinds, Ginette A. .
JAMA DERMATOLOGY, 2015, 151 (06) :668-670
[7]   Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States [J].
Cosmatos, Irene ;
Matcho, Amy ;
Weinstein, Rachel ;
Montgomery, Michael O. ;
Stang, Paul .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (03) :412-419
[8]   Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities [J].
Crowley, J. J. ;
Mekkes, J. R. ;
Zouboulis, C. C. ;
Scheinfeld, N. ;
Kimball, A. ;
Sundaram, M. ;
Gu, Y. ;
Okun, M. M. ;
Kerdel, F. .
BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (06) :1561-1565
[9]   Hidradenitis Suppurativa Management in the United States: An Analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases [J].
Davis, Scott A. ;
Lin, Hsien-Chang ;
Balkrishnan, Rajesh ;
Feldman, Steven R. .
SKIN APPENDAGE DISORDERS, 2015, 1 (02) :65-73
[10]  
Davis SA, 2012, J DRUGS DERMATOL, V11, P466